| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PRIMA-1-Met | CTRPv2 | pan-cancer | AAC | -0.081 | 0.1 |
| mRNA | BRD-K88742110 | CTRPv2 | pan-cancer | AAC | -0.057 | 0.1 |
| mRNA | OSI-027 | CTRPv2 | pan-cancer | AAC | 0.055 | 0.1 |
| mRNA | WZ3105 | GDSC1000 | pan-cancer | AAC | 0.047 | 0.1 |
| mRNA | RDEA119 | GDSC1000 | pan-cancer | AAC | -0.048 | 0.1 |
| mRNA | ouabain | CTRPv2 | pan-cancer | AAC | 0.054 | 0.1 |
| mRNA | BRD-K07442505 | CTRPv2 | pan-cancer | AAC | 0.057 | 0.1 |
| mRNA | GDC-0879 | CTRPv2 | pan-cancer | AAC | -0.054 | 0.1 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | -0.044 | 0.1 |
| mRNA | BRD-K42260513 | CTRPv2 | pan-cancer | AAC | -0.088 | 0.1 |